Deutsche Bank AG Has $1.44 Million Stock Holdings in Surgery Partners, Inc. $SGRY

Deutsche Bank AG decreased its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 37.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,556 shares of the company’s stock after selling 35,956 shares during the period. Deutsche Bank AG’s holdings in Surgery Partners were worth $1,438,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. grew its stake in shares of Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company’s stock worth $91,000 after buying an additional 465 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Surgery Partners by 86.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock valued at $28,000 after acquiring an additional 542 shares in the last quarter. Mackenzie Financial Corp grew its position in Surgery Partners by 2.8% during the 4th quarter. Mackenzie Financial Corp now owns 21,974 shares of the company’s stock worth $465,000 after acquiring an additional 599 shares during the last quarter. Wells Fargo & Company MN increased its holdings in Surgery Partners by 1.4% in the 4th quarter. Wells Fargo & Company MN now owns 56,931 shares of the company’s stock worth $1,205,000 after purchasing an additional 783 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in Surgery Partners by 0.3% in the 1st quarter. Bank of New York Mellon Corp now owns 341,702 shares of the company’s stock worth $8,115,000 after purchasing an additional 926 shares in the last quarter.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $23.64 on Friday. The stock has a market capitalization of $3.03 billion, a PE ratio of -16.53 and a beta of 1.82. The business’s 50 day simple moving average is $22.13 and its 200 day simple moving average is $22.91. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78. Surgery Partners, Inc. has a one year low of $18.87 and a one year high of $33.97.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The firm had revenue of $826.20 million for the quarter, compared to the consensus estimate of $816.96 million. During the same quarter in the previous year, the company earned $0.21 EPS. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. As a group, research analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Teresa Deluca sold 20,018 shares of the business’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $22.74, for a total value of $455,209.32. Following the transaction, the director owned 45,173 shares in the company, valued at $1,027,234.02. The trade was a 30.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts have recently commented on SGRY shares. Bank of America began coverage on Surgery Partners in a research note on Monday, July 28th. They set a “buy” rating and a $28.00 price target on the stock. Barclays cut their target price on shares of Surgery Partners from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 27th. Six analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $33.00.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.